Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

No abstract is available for this paper.

• Publication year

  2000

• Venue

  British Journal of Pharmacology

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjp.0703690PMID 11090097PMCID PMC1572453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contractile responses to human urotensin‐II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

  2000influential reference
• UROTENSIN II: BETTER THAN SOMATOSTATIN FOR PORTAL HYPERTENSION?

  2000cited by this paper
• Urotensin II: better than somatostatin for portal hypertension?

  2000cited by this paper
• Endothelins are potent vasoconstrictors, and much more besides.

  2000cited by this paper
• Urotensin II: fish neuropeptide catches orphan receptor.

  2000cited by this paper
• Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteries

  2000influential reference
• Human urotensin‐II is a potent spasmogen of primate airway smooth muscle

  2000cited by this paper
• Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

  1999influential reference
• Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.

  1999influential reference
• Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• The physiological response to cardiovascular 'orphan' G protein-coupled receptor agonists

  1999cited by this paper
• A homologous radioimmunoassay for the measurement of urotensin II in the euryhaline flounder, Platichthys flesus.

  1999cited by this paper
• Native urotensins influence cortisol secretion and plasma cortisol concentration in the euryhaline flounder, platichthys flesus.

  1998cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Orphan G‐protein‐coupled receptors: the next generation of drug targets?

  1998cited by this paper
• Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives.

  1997cited by this paper
• Signal transduction mechanisms mediating the vascular actions of endothelin.

  1997cited by this paper
• Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery.

  1997cited by this paper
• Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates.

  1996cited by this paper
• A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia.

  1995cited by this paper
• Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein

  1995cited by this paper
• Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.

  1995cited by this paper
• Spasmogenic actions of frog urotensin II on the bladder and ileum of the frog, Rana catesbeiana.

  1994cited by this paper
• Neural cell adhesion molecules are present in the fetal human primary olfactory pathway.

  1992cited by this paper
• Contraction of rat thoracic aorta strips by endothelin‐1 in the absence of extracellular Ca2+

  1991cited by this paper
• Functional receptors for fish neuropeptide urotensin II in major rat arteries.

  1988cited by this paper
• The influence of urotensin II on calcium flux in rat aorta

  1988cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Complex effects of Gillichthys urotensin II on rat aortic strips

  1987cited by this paper
• Contraction of major artery segments of rat by fish neuropeptide urotensin II.

  1987influential reference
• Contraction of rat thoracic aorta strips induced by phorbol 12-myristate 13-acetate.

  1987cited by this paper
• Cardiovascular effects of urotensin II in anesthetized and pithed rats.

  1986cited by this paper
• Radioimmunoassays for fish tail neuropeptides: II. Development of a specific and sensitive assay for and the occurrence of immunoreactive urotensin II in the central nervous system and blood of Catostomus commersoni.

  1986cited by this paper
• Both somatostatin and the caudal neuropeptide, urotensin II, stimulate lipid mobilization from coho salmon liver incubated in vitro.

  1986cited by this paper
• Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes.

  1985cited by this paper
• Ion transport in goby intestine: cellular mechanism of urotensin II stimulation.

  1985cited by this paper
• Neuropeptide-induced contraction and relaxation of the mouse anococcygeus muscle.

  1984cited by this paper
• The fish urotensins: hypophyseal and peripheral actions in fishes and mammals

  1984cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper
• Pharmacological Analysis of Urotensin-induced Contraction and Relaxation in Isolated Rabbit Aortas

  1979cited by this paper
• A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts.

  1969cited by this paper

• Urotensin II system contributes to ischemic acute kidney injury in neonatal pigs

  2025cites this paper
• Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling

  2025cites this paper
• 2-{N-[(2,4,5-trichlorophenoxy) acetyl]-N-methylamino}-3-pyrrolidinepropanamide analogs as potential antagonists of Urotensin II receptor

  2023cites this paper
• Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats

  2023cites this paper
• Urotensin receptor in GtoPdb v.2021.3

  2021cites this paper
• An Integral Approach for Understanding the Bioactive Small Molecules in Cardiovascular Diseases

  2020cites this paper
• Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.

  2020cites this paper
• Association of resistin (rs3745367) and urotensin II (rs228648 and rs2890565) gene polymorphisms with risk of type 2 diabetes mellitus in Indian population

  2020cites this paper
• Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities

  2020cites this paper
• Urotensin receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Développement d'analogues urotensinergiques radiomarqués pour l'imagerie de tumeurs solides

  2018cites this paper
• Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II.

  2017cites this paper
• Key molecules and factors – Excessive arterial vasodilation / hypocontractility

  2017cites this paper
• Insight into the role of urotensin II‐related peptide tyrosine residue in UT activation

  2017cites this paper
• Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression

  2017cites this paper
• Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.

  2017cites this paper
• Pulmonary artery hypertension: pertinent vasomotorial cytokines

  2017cites this paper
• Acute Effect of Central Administration of Urotensin II on Baroreflex and Blood Pressure in Conscious Normotensive Rabbits

  2017cites this paper
• The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow

  2016cites this paper
• Blockade of Urotensin II Receptor Prevents Vascular Dysfunction

  2016influential citation
• Renal Urotensin II System Plays Roles in the Regulation of Blood Pressure in Dahl Salt-Resistant Rat

  2016cites this paper
• Genetic polymorphisms of UTS2 rs2890565 Ser89Asn in cardiac hypertrophy in Chinese Han population

  2016cites this paper
• Pathogenesis of Macrovascular Complications in Diabetes

  2016cites this paper
• vasoconstrictionangiotensin II and in urotensin II-induced Role of PKC in the novel synergistic action of urotensin II

  2016cites this paper
• A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.

  2016cites this paper
• The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification

  2016cites this paper
• Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

  2015cites this paper
• Effect of Different Peptides

  2015cites this paper
• Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase.

  2015cites this paper
• Related Peptide, and Their Receptor: From Structure to Function - International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II

  2015cites this paper
• Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015influential citation
• Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.

  2014cites this paper
• Therapeutic implications of peptide interactions with G‐protein‐coupled receptors in diabetic vasculopathy

  2014cites this paper
• Molecular evolution of GPCRs: Somatostatin/urotensin II receptors.

  2014cites this paper
• The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study

  2014cites this paper
• Urotensin II increases foam cell formation by repressing ABCA1 expression through the ERK/NF-κB pathway in THP-1 macrophages.

  2014cites this paper
• The Importence of Urotensin and Urotensin Receptors in Cardiovascular System

  2014cites this paper
• Urotensin-II System in Genetic Control of Blood Pressure and Renal Function

  2013cites this paper
• Crosstalk between VEGF and BMP9 Signalling in the Context of Preeclampsia

  2013cites this paper
• Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis.

  2013cites this paper
• Chemerin Connects Fat to Arterial Contraction

  2013cites this paper
• Clinical & Neurohormonal Predictors of Outcome after Electrical Cardioversion for Atrial Fibrillation

  2013cites this paper
• Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma

  2013influential citation
• Analysis of genetic variation within urotensin-II system in regulation of blood pressure and renal function

  2013influential citation
• RGS2 Regulates Urotensin II‐Induced Intracellular Ca2+ Elevation and Contraction in Glomerular Mesangial Cells

  2013cites this paper
• Pressor and renal regional hemodynamic effects of urotensin II in neonatal pigs

  2013cites this paper
• HUMAN PRIMARY ALDOSTERONISM : FROM CLINICAL OBSERVATIONS TO IN-VIVO AND EX-VIVO STUDIES ON THE PRESSOR EFFECTS OF UROTENSIN II

  2013cites this paper
• Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.

  2013cites this paper
• Contractile responses to rat urotensin II in resting and depolarized basilar arteries

  2013cites this paper
• Chapter 195 – Urotensin Peptides

  2013cites this paper
• CHEMICAL DESCRIPTION OF THE INTERACTION BETWEEN GLYCAN LIGAND AND SIGLEC-7 USING AB INITIO FMO METHOD AND CLASSICAL MD SIMULATION

  2013cites this paper
• The Molecules: Abnormal Vasculatures in the Splanchnic and Systemic Circulation in Portal Hypertension"

  2012cites this paper
• Nouvelles stratégies de prise en charge de l'hypertension pulmonaire périnatale

  2012cites this paper
• New Therapeutics in Hypertension

  2012cites this paper
• A closer look at the role of urotensin II in the metabolic syndrome

  2012cites this paper
• Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?

  2012cites this paper
• Endothelial dysfunction in the regulation of cirrhosis and portal hypertension

  2012cites this paper
• Genetic and Pharmacological Manipulation of Urotensin II Ameliorate the Metabolic and Atherosclerosis Sequalae in Mice

  2012cites this paper
• The Efficiency of a Urotensin II Antagonist in an Experimental Lung Fibrosis Model

  2011cites this paper
• Urotensin‐2 promotes collagen synthesis via ERK1/2‐dependent and ERK1/2‐independent TGF‐β1 in neonatal cardiac fibroblasts

  2011cites this paper
• Angioprotectin: an angiotensin II‐like peptide causing vasodilatory effects

  2011cites this paper
• In Vitro Manipulation of Urotensin-II Receptor Expression: Implications of Receptor Density on Ligand Efficacy

  2011influential citation
• Urotensin II differentially regulates macrophage and hepatic cholesterol homeostasis.

  2011cites this paper
• Potential Clinical Implications of the Urotensin II Receptor Antagonists

  2011influential citation
• Expression of Urotensin II and Its Receptor in Human Liver Cirrhosis and Fulminant Hepatic Failure

  2010cites this paper
• Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension.

  2010cites this paper
• Working under pressure: coronary arteries and the endothelin system.

  2010cites this paper
• The Pathogenesis of Macrovascular Complications Including Atherosclerosis in Diabetes

  2010cites this paper
• Urotensin II: a novel target in human corpus cavernosum.

  2010cites this paper
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo.

  2010cites this paper
• GSK1562590, a slowly dissociating urotensin‐II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo

  2010influential citation
• rotein expression of urotensin II , urotensin-related peptide and their eceptor in the lungs of patients with lymphangioleiomyomatosis

  2010cites this paper
• Suche, Reinigung und Identifizierung eines Urotensin II metabolisierenden Enzyms

  2010cites this paper
• The cardiovascular physiology and pharmacology of endothelin-1.

  2010cites this paper
• Ligand supported purification of the Urotensin-II receptor

  2010influential citation
• Urotensin II, from fish to human

  2010cites this paper
• Ligand-Supported Purification of the Urotensin-II Receptor

  2010influential citation
• Upregulation of Urotensin II Receptor in Preeclampsia Causes In Vitro Placental Release of Soluble Vascular Endothelial Growth Factor Receptor 1 in Hypoxia

  2010cites this paper
• Role of urotensin II in health and disease.

  2010influential citation
• Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.

  2009cites this paper
• Human urotensin-II receptor desensitisation

  2009cites this paper
• Pharmacokinetics and Pharmacodynamics of the Urotensin‐II Receptor Antagonist Palosuran in Healthy Male Subjects

  2009cites this paper
• Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas.

  2009cites this paper
• Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

  2009cites this paper
• Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release.

  2009cites this paper
• Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double‐blind placebo‐controlled crossover trial

  2009cites this paper
• Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats.

  2009cites this paper
• Urotensin II induces transactivation of the epidermal growth factor receptor via transient oxidation of SHP-2 in the rat renal tubular cell line NRK-52E

  2009cites this paper
• Involvement of Novel Cardiac Peptides in Healthy and Ischemic Hearts

  2009influential citation
• Urotensin II Receptor Knockout Mice on an ApoE Knockout Background Fed a High-Fat Diet Exhibit an Enhanced Hyperlipidemic and Atherosclerotic Phenotype

  2009cites this paper
• Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.

  2009cites this paper
• Role of urotensin II in atherosclerotic cardiovascular diseases.

  2008cites this paper
• Urotensin II and atherosclerosis.

  2008cites this paper
• Increased circulating urotensin II in cirrhosis: potential implications in liver disease.

  2008cites this paper
• Three‐dimensional model of the human urotensin‐II receptor: Docking of human urotensin‐II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model

  2008cites this paper
• Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.

  2008cites this paper
• Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.

  2008cites this paper